Dynamic contrast-enhanced CT to assess metabolic response in patients with advanced non-small cell lung cancer and stable disease after chemotherapy or chemoradiotherapy.
about
Imaging techniques for tumour delineation and heterogeneity quantification of lung cancer: overview of current possibilitiesGambogenic acid kills lung cancer cells through aberrant autophagyBiological imaging in clinical oncology: radiation therapy based on functional imaging.Three-dimensional texture analysis of contrast enhanced CT images for treatment response assessment in Hodgkin lymphoma: comparison with F-18-FDG PET.CT imaging features associated with recurrence in non-small cell lung cancer patients after stereotactic body radiotherapy.
P2860
Dynamic contrast-enhanced CT to assess metabolic response in patients with advanced non-small cell lung cancer and stable disease after chemotherapy or chemoradiotherapy.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Dynamic contrast-enhanced CT t ...... otherapy or chemoradiotherapy.
@en
Dynamic contrast-enhanced CT t ...... otherapy or chemoradiotherapy.
@nl
type
label
Dynamic contrast-enhanced CT t ...... otherapy or chemoradiotherapy.
@en
Dynamic contrast-enhanced CT t ...... otherapy or chemoradiotherapy.
@nl
prefLabel
Dynamic contrast-enhanced CT t ...... otherapy or chemoradiotherapy.
@en
Dynamic contrast-enhanced CT t ...... otherapy or chemoradiotherapy.
@nl
P2093
P2860
P1433
P1476
Dynamic contrast-enhanced CT t ...... otherapy or chemoradiotherapy.
@en
P2093
Sang Jin Kim
Sung Ho Hwang
Tae Hoon Kim
Tae Joo Jeon
P2860
P2888
P304
P356
10.1007/S00330-012-2755-0
P407
P577
2013-01-09T00:00:00Z